Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests

New England Journal of Medicine

Volumn 339, Issue 3, 1998, Pages 153-159

  Rockey, Don C ^a   Koch, Johannes ^b   Cello, John P ^b   Sanders, Linda L ^a   McQuaid, Kenneth ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; COLITIS; COLON ADENOMA; COLON CARCINOMA; COLON DISEASE; COLONOSCOPY; DUODENUM ULCER; ESOPHAGITIS; FEMALE; GASTRITIS; GASTROINTESTINAL DISEASE; GASTROSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; OCCULT BLOOD TEST; PRIORITY JOURNAL; STOMACH ULCER;

AGED; COLONIC DISEASES; ENDOSCOPY, DIGESTIVE SYSTEM; FALSE POSITIVE REACTIONS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OCCULT BLOOD; PREVALENCE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0032537740     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199807163390303     Document Type: Article

References (36)

1. Mandel IS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328:1365-71. [Erratum, N Engl J Med 1993;329:672.]
2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
3. Hardcastle ID, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
4. Lance P. Fecal occult blood tests: what's new? Gastroenterology 1993; 104:1852-5.
5. Lieberman DA. Colon cancer screening: the dilemma of positive screening tests. Arch Intern Med 1990;150:740-4.
6. Ransohoff DF, Lang CA. Screening for colorectal cancer. N Engl J Med 1991;325:37-41.
7. Young GP, St John DJ. Screening for colorectal cancer: the accuracy of fecal occult blood. JAMA 1993;270:451-2.
8. Lieberman D, Sleisenger MH. Is it time to recommend screening for colorectal cancer? Lancet 1996;348:1463-4.
9. Greenberg PD, Cello JP, Rockey DC. Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease. Am J Med 1996;100:598-604.
10. Ahlquist DA, McGill DB, Schwartz S, Taylor WF, Owen RA. Fecal blood levels in health and disease: a study using HemoQuam. N Engl J Med 1985;312:1422-8.
11. Morris DW, Hansell JR, Ostrow JD, Lee CS. Reliability of chemical tests for fecal occult blood in hospitalized patients. Am J Dig Dis 1976;21: 845-52.
12. Stroehlein JR, Fairbanks VF, McGill DB, Go VL. Hemoccult detection of fecal occult blood quantitated by radioassay. Am J Dig Dis 1976; 21:841-4.
13. Dybdahl JH. Occult faecal blood loss determined by a 51Cr method and chemical tests in patients referred for upper gastrointestinal endoscopy. Scand J Gastroenterol 1984;19:235-44.
14. Herzog P, Holtermuller KH, Preiss J, et al. Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test. Gastroenterology 1982;83:957-62.
15. Macrae FA, St John DJ. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982;82:891-8.
16. World Medical Association Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-6.
17. Ferguson A, Brydon WG, Brian H, Williams A, Mackie MJ. Use of whole gut perfusion to investigate gastrointestinal blood loss in patients with iron deficiency anaemia. Gut 1996;38:120-4.
18. Dybdahl JH, Daae LN, Larsen S, Myren J. Occult faecal blood loss determined by a 51Cr method and chemical tests in patients referred for colonoscopy. Scand J Gastroenterol 1984;19:245-54.
19. Sontag SJ, Hirschowitz BI, Holt S, et al. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study. Gastroenterology 1992;102:109-18.
20. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston: PWS-Kent, 1988.
21. SAS/STAT user's guide. 4th ed. Vol. 2. Cary, N.C.: SAS Institute, 1990.
22. St John DJ, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993; 104:1661-8.
23. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334:155-9.
24. Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value: long-term follow-up in a large group practice setting. Ann Intern Med 1990;112:328-33.
25. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer: is mortality reduced by chance selection for screening colonoscopy? JAMA 1994;271:1011-3.
26. Ostrow JD, Mulvaney CA, Hansell JR, Rhodes RS. Sensitivity and reproducibility of chemical tests for fecal occult blood with an emphasis on false-positive reactions. Am J Dig Dis 1973;18:930-40.
27. Rockey D, Auslander A, Greenberg P. Detection of occult upper gastrointestinal blood with fecal occult blood tests. Gastroenterology 1997; 112:Suppl:A40. abstract.
28. Akdamar K, Ertan A, Agrawal NM, McMahon FG, Ryan J. Upper gastrointestinal endoscopy in normal asymptomatic volunteers. Gastrointest Endosc 1986;32:78-80.
29. Johnsen R, Bernersen B, Straume B, Forde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ 1991;302:749-52.
30. Marks RD, Hall G, Veerapalli R, Singh S. Fecal occult blood testing: does the stool collection method affect outcomes? Gastroenterology 1997; 112:Suppl:A29. abstract.
31. Brim SL, DiPalma JA, Herrera JL. Is a Hemoccult-positive rectal examination clinically significant? South Med J 1993;86:601-3.
32. Eisner MS, Lewis JH. Diagnostic yield of a positive fecal occult blood test found on digital rectal examination: does the finger count? Arch Intern Med 1991;151:2180-4.
33. Geller AJ, Koks BE, Achem SR, Wears R. The high frequency of upper gastrointestinal pathology in patients with fecal occult blood and colon polyps. Am J Gastroenterol 1993;88:1184-7.
34. Chen YK, Gladden DR, Kestenbaum DJ, Collen MJ. Is there a role for upper gastrointestinal endoscopy in the evaluation of patients with occult blood-positive stool and negative colonoscopy? Am J Gastroenterol 1993;88:2026-9.
35. Hsia PG, al-Kawas FH. Yield of upper endoscopy in the evaluation of asymptomatic patients with Hemoccult-positive stool after a negative colonoscopy. Am J Gastroenterol 1992;87:1571-4.
36. Zuckerman G, Benitez J. A prospective study of bidirectional endoscopy (colonoscopy and upper endoscopy) in the evaluation of patients with occult gastrointestinal bleeding. Am J Gastroenterol 1992;87:62-6.